![[H-3] L-655,708](https://strapi.rctritec.com/uploads/image_2_c0fa466e8c.png)
[H-3] L-655,708
En stock et expédié sous 1 à 2 semainesQuantité
Key Facts
- Numéro de catalogue
- RCTT0581
- CAS
- 130477-52-0
- Formule moléculaire
- C18H19N3O4
- Poids moléculaire
- 341.36 g/mol
- Specific Activity Range
- 60-87 Ci/mmol (2220-3220 GBq/mmol)
- Concentration
- 1.0 mCi/ml (37 MBq/ml) in ethanol.
Description
Subtype-selective inverse agonist of the benzodiazepine binding site of the GABAA receptor.
Caractéristiques techniques
- Nom du produit
- [H-3] L-655,708
- Numéro de catalogue
- RCTT0581
- Numéro CAS
- 130477-52-0
- Formule moléculaire
- C18H19N3O4
- Poids moléculaire
- 341.36 g/mol
- Concentration
- 1.0 mCi/ml (37 MBq/ml) in ethanol.
- Pureté radiochimique
- The radiochemical purity after purification was determined to be >97%.
- Activité spécifique
- 60-87 Ci/mmol (2220-3220 GBq/mmol)
- Expédition
- Shipped at ambient temperature.
Stockage et stabilité
The initial rate of degradation of this compound, stored as received, at temperatures below -60 °C in the dark, is about 1% per month starting from the date of purification. The decomposition of the compound is not linear or related to isotope half-life. Deviations of different lots may occur.
Sécurité et conformité
The mass spectrum is consistent with the proposed structure and a non-labeled reference; the HPLC retention time is consistent with a non-labeled reference. For research and development use only, not for use in humans. This compound could induce cancer.